ArticleSouth Asian journal of cancer2025

Efficacy and Safety Profile of Different Schedules of Adjuvant Trastuzumab Therapy among Patients with HER2-Positive Breast Cancer: Real-World Experience from a Tertiary Cancer Center in South India.

Nandini Devi Rajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.